It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year

Aytu BioPharma's EPS increased by 71% in three years, but shareholders experienced a 97% loss. Shareholders can address concerns at the upcoming AGM on June 26, including CEO compensation.